Dr. Maldonado joins Koya as Chief Medical Officer and member of the Medical Advisory Board
OAKLAND, Calif., Dec. 27, 2022 /PRNewswire/ -- Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, today announced the addition of Dr. Thomas Maldonado as Chief Medical Officer. The addition of Dr. Maldonado further strengthens Koya Medical's clinical advisory board, led by Stanley Rockson, M.D., cardiologist and professor in the Falk Cardiovascular Research Center at Stanford University School of Medicine.
Continue Reading
Preview
Source: PRNewswire
Dr. Thomas Maldonado
Thomas Maldonado, M.D. has been one of New York City's top vascular surgeons in one of the nation's premier academic medical centers for over two decades. He is regularly featured as Top Doctor by Castle Connolly and has served as president of numerous national and regional vascular societies. Dr. Maldonado, who is devoted to unrivaled patient care and research, states that he is "honored to serve as Chief Medical Officer for Koya Medical and looks forward to continuing to advance the Dayspring to help even more people with lymphedema and venous diseases maintain mobility while receiving effective compression treatment."
Dr. Maldonado, Professor of Surgery, is a prolific researcher and academician with over 150 publications in the field of vascular surgery and serves as editor-in-chief for the journal, Vascular and Endovascular Surgery. Additionally, Dr. Maldonado is an innovator in minimally invasive endovascular therapy. He is nationally and internationally recognized for his surgical skill as well as his commitment to education and advancing patient care.
The Dayspring system is the first wearable and mobility-enabled active compression system designed with real life in mind. It is the first compression treatment option designed to enable movement, mobility, and personalized care that is unavailable with existing traditional pneumatic compression. The Dayspring system includes a low-profile active garment made of soft, breathable mesh using Koya's proprietary Flexframe® technology; a smart, rechargeable, hand-held controller that can be worn on a lanyard; and a mobile app that allows users or their clinicians to track therapy and customize treatment options.
Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases to increase movement, mobility, and personalized care that is unavailable with traditional compression therapy. The privately held company was founded in 2018 with the mission to transform lymphatic and vein care through innovative patient-centric platforms. For company or product inquiry, contact [email protected]. Follow us on LinkedIn at www.linkedin.com/company/koyamedical/.
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.